Pharmaceutical industry – Page 18
-
ArticleExploring the advantages of single-crystal x-ray diffraction in pharma
Single-crystal x-ray diffraction (SCXRD) in drug development is evolving. Johnson Matthey outlines how technology advances and regulations are reshaping its role in pharma
-
OpinionFacing the challenge of vaccine trials
Russia’s Covid-19 gamble is a stark contrast to even accelerated clinical programmes
-
BusinessRussian vaccine launch shocks scientists
Sputnik V to be approved without large human trial data
-
BusinessEncouraging signs from initial Covid-19 vaccine trials
Human trials deliver positive immune responses, while primate challenge studies suggest protection is possible
-
ArticleInnovating in complex environments
The benefits of digital tools and automation with no programming required
-
BusinessDeadly Indian incidents highlight relaxed regulations
Concern over human and environmental cost of reforms aimed at ease of doing business
-
-
OpinionLooking beyond the next wave
We need to apply lessons from Covid-19 to tackle antimicrobial resistance and climate change
-
BusinessWhat are the risks of fast-tracking a Covid-19 vaccine?
Condensing timelines from years to months inevitably involves compromises
-
ArticleCatalysts for collaboration
Demand for greener, more sustainable technologies in pharma, agro and fine chemicals sectors is growing – catalysis is at the heart of this transformation
-
ArticleCatalysis and chemical bonds that make us stronger
Chemical and pharma industry is built on collaboration that draws on a wide range of expertise to develop innovative materials, compounds and components
-
BusinessScrambling and gambling to scale up Covid-19 medicines
Organisations work towards making billions of doses of products not yet proven to work
-
OpinionDragons of immunology
Anti-inflammatories like dexamethasone are triumphs amid the pitfalls of the immune system
-
NewsCovid-19 is forcing pharma to rethink clinical trials
Drug trials have become a casualty of Covid-19, but the pandemic is also prompting change
-
NewsUS chemical plants risk disastrous cyberattacks relying on guidance a decade out of date
Cybersecurity guidelines for chemical plants urgently need updating and inspectors need training, report finds
-
BusinessHow Covid-19 is changing drug manufacturing
Catalent is adapting, focusing on employee safety and supply chain security
-
BusinessThis little Crispr went to market
Gene editing technology heading towards commercial reality in pharmaceuticals, food and organ transplant
-
OpinionHopes and fears for remdesivir
Available resources for testing coronavirus treatments need to be used wisely
-
OpinionDoes the drug work, or not?
Coronavirus trials reveal the murky reality of disentangling compounds’ effects on human biology
-
BusinessMicropore Technologies’ model membranes make exact emulsions
Solving scalability issues to control particle size without high-shear mixing